revers
transcriptas
rt
human
immunodefici
viru
hiv
encod
pol
gene
multifunct
enzym
possess
rna
dnadepend
polymeras
activ
well
rnase
h
activ
rt
indispens
convert
singlestrand
viral
rna
doublestrand
dna
upon
viral
entri
host
cell
due
import
role
viral
life
cycl
rt
one
attract
target
antivir
drug
design
biolog
activ
form
rt
heterodim
consist
two
subunit
kda
kda
subunit
deriv
proteolyt
cleavag
ctermin
domain
polymeras
domain
resembl
right
hand
configur
consist
four
subdomain
known
finger
palm
thumb
connect
finger
palm
thumb
subdomain
form
nucleic
acid
bind
cleft
connect
subdomain
two
subunit
form
floor
nucleic
acid
bind
site
thumb
subdomain
four
helic
two
antiparallel
import
hold
primertempl
posit
transloc
polymer
primari
sequenc
vicin
two
helic
found
share
homolog
sever
nucleic
acid
polymeras
term
helix
clamp
extens
studi
carri
shed
light
relationship
helix
clamp
function
rt
effect
alaninescan
mutat
polymeras
activ
primertempl
pt
bind
fidel
enzym
kinet
determin
mutat
affect
pt
bind
fidel
significantli
sever
mutant
exhibit
lower
bind
affin
process
frameshift
fidel
previou
studi
demonstr
mutat
two
helic
signific
effect
rnase
h
activ
minusstrand
dna
transfer
activ
remov
polypurin
track
primer
although
alanin
substitut
site
investig
two
studi
detail
studi
function
structur
turn
limit
previou
studi
hepat
b
viru
rt
conserv
residu
locat
turn
helix
clamp
motif
found
import
pregenom
rna
encapsid
assembl
nucleocapsid
sinc
homolog
helix
clamp
motif
also
present
rt
hypothes
residu
turn
may
play
import
role
viral
life
cycl
recent
studi
show
alanin
substitut
rt
drastic
affect
viral
replic
discord
viral
replic
rt
activ
observ
studi
confirm
previou
observ
investig
two
mutat
abrog
viral
replic
studi
demonstr
two
mutat
lead
rapid
degrad
rt
viral
particl
indic
residu
critic
maintain
stabil
hiv
rt
parent
provir
plasmid
phefvsvg
obtain
nih
aid
research
refer
reagent
program
divis
aid
niaid
nih
base
mutant
base
mutant
construct
sitedirect
mutagenesi
use
quikchang
ii
xl
sitedirect
mutagenesi
kit
stratagen
usa
accord
manufactur
instruct
open
read
frame
rt
subunit
amplifi
wild
type
mutant
use
pair
primer
clone
vector
novagen
shanghai
obtain
express
plasmid
tag
terminu
pair
primer
use
sitedirect
mutagenesi
construct
plasmid
list
tabl
cell
line
hela
maintain
dulbecco
modifi
eagl
medium
dmem
supplement
fetal
bovin
serum
antibiot
invitrogen
usa
cell
maintain
rpmi
supplement
fetal
bovin
serum
antibiot
prepar
pseudovirus
live
virus
cell
cotransfect
wildtyp
mutant
phefvsvg
wildtyp
mutant
use
lipofectamin
invitrogen
usa
accord
manufactur
instruct
supernat
collect
h
transfect
store
spin
filter
remov
cell
debri
cell
rins
icecold
phosphatebuff
salin
pb
scrape
plate
lyze
cell
lysi
buffer
boehring
germani
proteas
inhibitor
cocktail
roch
usa
ice
min
cell
lysat
store
centrifug
min
remov
cell
debri
one
cycl
infect
assay
carri
use
normal
pseudovirus
describ
previous
briefli
jurkat
cell
infect
viral
supernat
contain
ng
measur
vironostika
antigen
microelisa
kit
biomerieux
bv
boxtel
netherland
viru
cell
mixtur
spun
g
h
spin
infect
jurkat
cell
wash
ml
cultur
medium
twice
cultur
plate
h
cell
collect
wash
twice
pb
cell
fix
paraformaldehyd
pb
min
ice
infect
cell
determin
express
gfp
measur
use
facscalibur
instrument
becton
dickinson
usa
analyz
cell
quest
softwar
becton
dickinson
usa
describ
previous
infect
live
virus
conduct
cell
cell
infect
normal
wild
type
mutant
live
virus
plate
describ
previous
briefli
triplic
well
cellswel
infect
live
virus
pg
dilut
dmem
contain
deaedextran
amersham
bioscienc
cultur
incub
h
cell
fix
glutaraldehyd
pb
min
wash
twice
pb
cell
stain
xgal
galactopyranosid
mm
mm
potassium
ferrocyanid
mm
potassium
ferricyanid
pb
h
plate
wash
twice
pb
blue
foci
observ
microscop
infect
live
virus
also
carri
cell
describ
previous
brief
cell
cellswel
plate
infect
live
virus
pg
cultur
day
virusspecif
cytopath
effect
cpe
observ
microscop
rt
activ
pseudovirus
measur
rt
assay
use
colorimetr
kit
roch
usa
briefli
viral
supernat
contain
centrifug
h
viral
pellet
resuspend
lysi
buffer
lyze
viral
pellet
fold
serial
dilut
subsequ
procedur
carri
accord
manufactur
instruct
rt
activ
mutant
calcul
compar
wild
type
pseudoviru
express
subcellular
local
precursor
galpol
polyprotein
detect
immunofluoresc
microscopi
describ
previous
modif
briefli
hela
cell
cultur
coverslip
cultur
plate
transfect
ng
ng
phefvsvg
two
day
posttransfect
cell
fix
paraformaldehyd
pfa
room
temperatur
min
wash
time
pb
mm
ammonium
chlorid
incub
cell
min
neutral
residu
pfa
cell
wash
time
pb
treat
triton
min
wash
time
pb
normal
rabbit
serum
nr
pb
ad
block
slip
overnight
primari
antibodi
mous
monoclon
antiintegras
santa
cruz
secondari
antibodi
texa
red
dyeconjug
rabbit
antimous
igg
jackson
immunoresearch
incub
sampl
dark
room
temperatur
follow
incub
sampl
subject
wash
nr
pb
addit
pb
wash
coverslip
mount
use
fluoresc
mount
medium
dako
observ
meta
confoc
microscop
carl
zeiss
galpol
polyprotein
product
test
western
blot
describ
previous
modif
briefli
viral
protein
separ
sdspolyacrylamid
gel
electrophoresi
sdspage
electroblot
onto
hybondp
pvdf
membran
ge
healthcar
bioscienc
block
skim
milk
h
room
temperatur
membran
incub
primari
antibodi
rabbit
polyclon
antirt
mous
monoclon
antirt
antiintergras
antiproteas
anticapsid
h
membran
wash
three
time
pb
contain
tween
pbst
incub
horseradish
peroxidas
hrp
conjug
secondari
antibodi
goat
antirabbit
igg
goat
antimous
igg
h
blot
rewash
three
time
pbst
signal
visual
use
ecl
western
blot
substrat
reagent
amersham
bioscienc
usa
kodak
biomax
scientif
imag
film
eastman
kodak
wild
type
mutant
express
vector
respect
transform
e
coli
express
induc
mm
isopropyl
iptg
e
coli
grew
e
coli
express
spun
resuspend
bind
buffer
mm
mm
nacl
mm
imidazol
bacteria
disrupt
ultrason
centrifug
g
min
wild
type
mutant
supernat
purifi
use
ninta
magnet
agaros
bead
qiagen
germani
purifi
protein
subject
nativepag
novex
bistri
gel
analysi
western
blot
accord
protocol
recommend
invitrogen
usa
rt
sequenc
strain
obtain
hiv
complet
sequenc
databas
http
wwwhivlanlgovcontentsequencenewalignalignhtml
align
compar
base
xray
crystal
structur
rt
research
collaboratori
structur
bioinformat
protein
data
bank
rcsb
pdb
structur
model
wild
type
mutant
rt
analyz
use
swisspdbview
softwar
http
spdbvvitalitch
statist
analysi
rt
activ
perform
student
test
use
stata
statist
softwar
result
consid
signific
effect
six
rt
mutat
helix
clamp
turn
rt
viral
replic
test
pseudovirus
jurkat
cell
infect
wild
type
mutant
pseudovirus
ng
cell
viral
replic
almost
complet
inhibit
mutant
replic
mutant
show
signific
differ
compar
wild
type
fig
similar
result
also
obtain
cell
infect
lower
amount
ng
pseudovirus
data
shown
confirm
result
replic
wild
type
live
virus
monitor
cell
mutant
undetect
cell
fig
virusspecif
cpe
found
cell
fig
sinc
revers
transcript
first
step
hiv
replic
viral
entri
host
cell
result
suggest
two
mutat
might
affect
rt
activ
thu
interrog
pseudoviru
mutant
rt
activ
rt
activ
recov
mutant
almost
unnotic
compar
wild
type
fig
result
confirm
use
wild
type
live
virus
data
shown
next
ask
viral
particl
contain
dysfunct
rt
rt
incorpor
viral
particl
western
blot
rt
protein
basic
undetect
viral
particl
two
mutant
fig
result
suggest
mutat
could
affect
incorpor
rt
viral
particl
lead
defect
revers
transcript
initi
viral
replic
next
investig
whether
loss
rt
viral
particl
mutant
attribut
alter
express
transport
precursor
protein
polyprotein
viru
assembl
lysat
cell
transfect
wild
type
mutant
detect
western
blot
shown
fig
similar
level
gag
protein
capsid
protein
ca
found
cell
transfect
wild
type
mutant
construct
indic
express
stabil
rt
precursor
protein
affect
mutat
immunofluoresc
stain
demonstr
normal
subcellular
local
mutant
gagpol
polyprotein
compar
wild
type
suggest
transport
gagpol
unlik
affect
alanin
substitut
fig
investig
whether
precursor
gagpol
polyprotein
inde
incorpor
pseudovir
particl
mutant
product
gagpol
polyprotein
integras
proteas
pr
wild
type
mutant
pseudovir
particl
examin
western
blot
result
show
except
rt
fig
product
gagpol
polyprotein
pr
ca
detect
mutant
level
similar
wild
type
pseudovir
particl
fig
thu
inde
incorpor
virion
process
properli
studi
rt
viral
particl
mutant
degrad
proteolysi
made
undetect
pseudovirus
wild
type
mutant
gener
presenc
absenc
indinavir
highli
specif
inhibitor
proteas
indinavir
treatment
effect
treatment
result
dosedepend
inhibit
process
wild
type
mutant
virus
fig
shown
fig
absenc
indinavir
rt
readili
detect
wild
type
pseudoviru
mutant
virus
presenc
indinavir
howev
rt
markedli
reduc
wild
type
viru
becam
detect
mutant
viral
particl
rt
also
detect
mutant
viru
also
detect
rt
subunit
viral
supernat
collect
earlier
time
point
hour
posttransfect
mutant
rt
still
undetect
data
shown
result
suggest
rt
degrad
incorpor
gagpol
polyprotein
virion
might
attribut
activ
viral
proteas
sinc
rt
dimer
stabl
form
remain
resist
proteolysi
test
whether
treatment
dimer
enhanc
could
reduc
mutant
rt
proteolysi
wild
type
mutant
pseudovirus
gener
presenc
absenc
efavirenz
efv
potent
dimer
enhanc
result
show
rt
mutant
still
undetect
presenc
efv
fig
conform
wild
type
mutant
rt
analyz
nativ
gel
electrophoresi
follow
western
blot
fig
nativ
condit
wild
type
subunit
form
homodim
howev
format
homodim
mutant
markedli
reduc
higher
order
oligom
appear
might
tetram
accord
molecular
weight
mutant
exist
least
two
higher
order
oligom
like
tetram
octam
base
molecular
weight
howev
exact
natur
oligom
form
mutant
subunit
remain
clarifi
furthermor
treatment
could
partial
disrupt
higher
order
oligom
improv
dimer
format
result
implic
dimer
format
might
necessari
stabil
rt
resist
proteolysi
incorpor
gagpol
polyprotein
viral
particl
compar
complet
sequenc
found
amino
acid
rel
conserv
shown
tabl
tyrosin
predomin
natur
exist
amino
acid
residu
phenylalanin
f
histidin
h
cystein
c
occur
rare
similarli
isoleucin
predomin
natur
exist
amino
acid
account
less
case
valin
v
leucin
l
found
site
find
suggest
amino
acid
might
probabl
play
import
role
maintain
activ
conform
rt
consist
structur
analysi
suggest
amino
acid
two
site
buri
thumb
region
rt
fig
reveal
wild
type
rt
rel
big
side
chain
absent
mutant
fig
thu
loss
side
chain
rt
mutant
plausibl
lead
conform
chang
rt
lead
aberr
dimer
format
suscept
proteolysi
proteas
hiv
rt
play
key
role
viral
replic
import
target
develop
antihiv
drug
howev
turn
helic
h
rt
thumb
region
amino
acid
residu
well
character
yet
understand
structurefunct
relationship
turn
detail
investig
whether
alanin
substitut
region
would
affect
rt
activ
except
residu
report
signific
influenc
rt
activ
residu
origin
alanin
six
mutant
pseudovirus
residu
construct
viral
replic
compar
wild
type
viru
replic
two
mutant
found
almost
complet
abolish
fig
result
confirm
live
viru
system
fig
sinc
report
bacteri
express
mutant
activ
wild
type
enzym
ask
whether
mutant
would
similarli
affect
rt
activ
viral
particl
result
show
rt
activ
basic
undetect
viral
particl
two
mutant
fig
also
found
loss
rt
activ
viral
particl
might
attribut
absenc
rt
viral
particl
rather
incorpor
dysfunct
rt
virion
fig
viral
entri
cell
first
step
replic
revers
transcript
result
thu
suggest
replic
mutant
virus
abrog
mutant
rt
exist
virion
sinc
rt
incorpor
virion
form
transport
cell
membran
viru
packag
interact
thu
investig
whether
mutat
would
affect
express
transport
result
show
properli
express
transport
cell
transfect
mutant
construct
fig
indic
mutat
affect
either
product
precursor
interact
found
inde
incorpor
virion
two
mutant
except
rt
product
includ
proteas
integras
could
detect
viral
particl
mutant
fig
although
report
domain
residu
rt
like
respons
rt
incorpor
studi
rule
involv
turn
anoth
report
suggest
two
mutat
rt
led
prematur
cleavag
gagpol
precursor
reduc
level
viral
enzym
virion
result
also
exclud
mutat
affect
cleavag
gagpol
precursor
viral
proteas
inhibit
assay
use
indinavir
final
demonstr
rt
mutant
degrad
incorpor
precursor
polyprotein
virion
degrad
associ
activ
viral
proteas
fig
result
indic
mutat
residu
would
reduc
stabil
rt
insid
viral
particl
render
suscept
viral
proteas
postincorpor
degrad
rt
report
previous
wapl
et
al
report
mutat
rt
inhibit
rt
dimer
result
reduc
steadyst
level
rt
subunit
viral
lysat
gagpol
affect
also
show
proteas
contribut
degrad
rt
subunit
virion
similar
result
also
observ
mutat
introduc
proteas
cleavag
site
rt
rnase
h
domain
anoth
mutat
subunit
also
report
abl
abrog
dimer
anoth
group
tri
gener
infecti
molecular
clone
simian
immunodefici
viru
found
glutam
acid
replac
posit
affect
stabil
rt
biolog
activ
stabl
form
rt
heterodim
consist
immedi
precursor
heterodim
homodim
proteolyt
remov
rnase
h
domain
one
homodim
subunit
proteas
lead
format
stabl
heterodim
rt
exist
equilibrium
mixtur
monom
dimer
includ
heterodim
homodim
among
heterodim
stabl
homodim
unstabl
plausibl
degrad
rt
report
previou
studi
may
ascrib
inhibit
rt
dimer
mutat
mechan
rt
degrad
virion
observ
studi
howev
may
differ
result
show
rt
mutant
still
undetect
virus
gener
presenc
potent
dimer
enhanc
fig
nativ
gel
analysi
show
dimer
form
rt
mutant
detect
although
markedli
reduc
compar
wild
type
mutant
could
form
dimer
instead
higher
order
oligom
rt
detect
mutant
fig
report
higher
order
oligomer
may
occur
rt
result
also
indic
substitut
may
chang
conform
rt
lead
oligomer
higher
order
oligom
form
mutant
perhap
tetram
octam
may
associ
instabl
rt
mutant
suscept
viral
proteas
furthermor
accord
locat
residu
fig
highli
probabl
alanin
substitut
andor
affect
conform
thumb
region
subsequ
interact
rnase
h
domain
result
exposur
h
cleavag
sequenc
subunit
consequ
proteolyt
degrad
proteas
rel
conserv
rt
residu
loss
big
side
chain
two
site
mutant
shown
structur
model
fig
also
support
import
role
tri
demonstr
vitro
treat
wild
type
mutant
rt
recombin
proteas
wild
type
rt
well
mutant
rt
could
digest
vitro
data
shown
result
consist
report
abram
praniak
could
explain
differ
proteolyt
stabil
rt
vitro
virion
taken
togeth
studi
show
alanin
substitut
residu
rt
could
caus
conform
chang
render
rt
unstabl
suscept
viral
proteas
thu
demonstr
turn
two
helic
may
import
maintain
protein
stabil
format
bioactiv
dimer
mutat
residu
rt
may
inactiv
viru
may
enter
cell
replic
find
may
prove
use
antihiv
drug
design
vaccin
develop
consid
emerg
resist
current
rt
inhibitor
turn
especi
amino
acid
residu
may
ideal
new
target
antivir
drug
design
agent
target
region
may
abl
affect
stabil
dimer
rt
subsequ
inhibit
viral
replic
moreov
potenti
drug
resist
mutat
region
especi
residu
may
probabl
inactiv
viru
prevent
appear
drugresist
viru
